Skip to main content

Advertisement

SpringerLink
Log in

Does parvovirus infection have a role in systemic lupus erythematosus?

  • Novel Aspects in Lupus, 2017
  • Published:
Immunologic Research Aims and scope Submit manuscript

Abstract

We sought to evaluate a possible link between parvovirus B19 infection and the clinical and laboratory expression of systemic lupus erythematosus (SLE). SLE patients were examined to evaluate their clinical status and disease activity. A complete Systemic Lupus Erythematosus Disease Activity Index (SLEDAI) score was obtained for each patient. In addition, we determined the level of systemic involvement throughout the course of the disease. Blood levels of IgM and IgG antibodies to parvovirus B19, levels of anti-dsDNA, C3, and C4 were measured. A PCR real-time assay was used to determine the presence of parvovirus B19 genetic material. The viral genome was found in sera of 2 of 51(3.9%) patients with SLE. There was no correlation between viral serology and the clinical and serological parameters of the disease. More SLE patients with secondary antiphospholipid syndrome (APS) had IgG and IgM antibodies to the virus (p < 0.029 and p < 0.018, respectively). These patients also had a higher titer of IgG antibodies to parvovirus B19 compared to SLE patients without APS. In this group of SLE patients, no association was found between parvovirus infection and the presence or activity of SLE. The results of the study suggest an association between parvovirus infection and antibody production directed against phospholipids.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Meyer O. Parvovirus B19 and autoimmune diseases. Joint Bone Spine. 2003;70:6–11.

    Article  PubMed  Google Scholar 

  2. Lehmann HW, von Landenberg P, Modrow S. Parvovirus B19 infection and autoimmune disease. Autoimmun Rev. 2003;2:218–23.

    Article  PubMed  Google Scholar 

  3. Hsu TC, Tsay GJ. Human parvovirus B19 infection in patients with SLE. Rheumatology. 2001;40:152–7.

    Article  CAS  PubMed  Google Scholar 

  4. Young N, Brown KE. Parvovirus B19. NEJM. 2004;350:586–97.

    Article  CAS  PubMed  Google Scholar 

  5. Severin MC, Levy Y, Shoenfeld Y. SLE and parvovirus B19: causal coincidence or causative culprit? Clin Rev Allergy Immunol. 2003;25:41–8.

    Article  PubMed  Google Scholar 

  6. Lehmann HW, Knoll A, Küster RM, Modrow S. Frequent infection with a viral pathogen, parvovirus B19, in rheumatic diseases of childhood. Arthritis Rheum. 2003;48:1631–8.

    Article  PubMed  Google Scholar 

  7. von Landenberg P, Lehmann HW, Knöll A, Dorsch S, Modrow S. Antiphospholipid antibodies in pediatric and adult patients with rheumatic disease are associated with parvovirus B19 infection. Arthritis Rheum. 2003;48:1939–47.

    Article  Google Scholar 

  8. Kurtzman G, Frickhofen N, Kimball J, Jenkins DW, Nienhuis AW, Young NS. Pure red cell aplasia of 10 years duration due to persistent parvovirus B19 infection and its cure with immunoglobulin therapy. NEJM. 1989;321:519–23.

    Article  CAS  PubMed  Google Scholar 

  9. Dorsch S, Liebisch G, Kaufmann B, von Landenberg P, Hoffmann JH, Drobnik W, et al. The VP1 unique region of parvovirus B19 and its constituent phospholipase A2-like activity. J Virol. 2002;76:2014–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Soderlund-Venermo M, Hokynar K, Nieminen J, Rautakorpi H, Hedman K. Persistence of human parvovirus B19 in human tissues. Pathol Biol. 2002;50:307–16.

    Article  CAS  PubMed  Google Scholar 

  11. Lunardi C, Tinazzi E, Bason C, Dolcino M, Corrocher R, Puccetti A. Human parvovirus B19 infection and autoimmunity. Autoimmun Rev. 2008;8:116–20.

    Article  CAS  PubMed  Google Scholar 

  12. von Landenberg P, Lehmann HW, Modrow S. Human parvovirus B19 infection and antiphospholipid antibodies. Autoimmun Rev. 2007;6:278–85.

    Article  Google Scholar 

  13. Aslanidis S, Pyrpasopoulou A, Kontotasios K, Doumas S, Zamboulis C. Parvovirus B19 infection and systemic lupus erythematosus: activation of an aberrant pathway? Eur J Intern Med. 2008;19:314–8.

    Article  PubMed  Google Scholar 

  14. Moffatt S, Tanaka N, Tada K, Nose M, Nakamura M, Muraoka O. A cytotoxic nonstructural protein, NS1, of human parvovirus B19 induces activation of interlukin-6 gene expression. J Virol. 1996;70:8485–91.

    CAS  PubMed  PubMed Central  Google Scholar 

  15. Ramos-Casals M, Cuadrado MJ, Alba P, Sanna G, Brito-Zerón P, Bertolaccini L, et al. Acute viral infections in patients with systemic lupus erythematosus. Medicine. 2008;87:311–8.

    Article  PubMed  Google Scholar 

  16. Suzuki T, Saito S, Hirabayashi Y, Harigae H, Ishii T, Kodera T, et al. Human parvovirus infection during the inactive stage of SLE. Intern Med. 2003;42:538–40.

    Article  PubMed  Google Scholar 

  17. Tóvári E, Mezey I, Hedman K, Czirják L. Self limiting lupus-like symptoms in patients with parvovirus B19 infection. Ann Rheum Dis. 2002;61:662–3.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Díaz F, Collazos J, Mendoza F, De La Viuda JM, Cazallas J, Urkijo JC. Systemic lupus erythematosus associated with acute parvovirus B19 infection. Clin Microbiol Infect. 2002;8:115–7.

    Article  PubMed  Google Scholar 

  19. Sugimoto T, Tsuda A, Uzu T, Kashiwagi A. Emerging lupus-like manifestations in acute parvovirus B19 infection. Clin Rheumatol. 2008;27:119–20.

    Article  PubMed  Google Scholar 

  20. Narváez Garcia FJ, Domingo-Domènech E, Castro-Bohorquez FJ, Biosca M, Garcia-Quintana A, Perez-Vega C. Lupus-like presentation of parvovirus B19 infection. Am J Med. 2001;111:573–5.

    Article  PubMed  Google Scholar 

  21. Hemauer A, Beckenlehner K, Wolf H, Lang B, Modrow S. Acute parvovirus B19 infection in connection with a flare of SLE in a female patient. J Clin Virol. 1999;4:73–7.

    Article  Google Scholar 

  22. Sève P, Ferry T, Koenig M, Cathebras P, Rousset H, Broussolle C. Lupus-like presentation of parvovirus B19 infection. Semin Arthritis Rheum. 2004;34:642–8.

    Article  Google Scholar 

  23. Bengtsson A, Widell A, Elmstâhl S, Sturfelt G. No serological indications that SLE is linked to exposure to human parvovirus B19. Ann Rheum Dis. 2000;59:64–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Kurtzman GJ, Cohen BJ, Field AM, Oseas R, Blaese RM, Young NS. Immune response to parvovirus B19 and an antibody defect in persistent viral infection. J Clin Invest. 1989;84:1114–23.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Tzang BS, Lee YJ, Yang TP, Tsay GJ, Shi JY, Tsai CC, et al. Induction of antiphospholipid antibodies and antiphospholipid syndrome-like autoimmunity in naive mice with antibody against human parvovirus B19 VP1 unique region protein. Clin Chim Acta. 2007;382(1–2):31–6.

    Article  CAS  PubMed  Google Scholar 

  26. Tzang BS, Tsay GJ, Lee YJ, Li C, Sun YS, Hsu TC. The association of VP1 unique region protein in acute parvovirus B19 infection and anti-phospholipid antibody production. Clin Chim Acta. 2007;378:59–65.

    Article  CAS  PubMed  Google Scholar 

  27. Chou TN, Hsu TC, Chen RM, Lin LI, Tsay GJ. Parvovirus B19 infection associated with the production of anti-neutrophil cytoplasmic antibody (ANCA) and anticardiolipin antibody (aCL). Lupus. 2000;9:551–4.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine E, Meir Medical Center, 44261, Kfar Saba, Israel

    Tami Hod, Pnina Rotman-Pikielny & Yair Levy

  2. Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

    Tami Hod, Giselle Zandman-Goddard, Pnina Langevitz, Hagit Rudnic, Zehava Grossman, Pnina Rotman-Pikielny & Yair Levy

  3. Department of Medicine C, Wolfson Medical Center, Holon, Israel

    Giselle Zandman-Goddard

  4. Rheumatology Unit, Sheba Medical Center, Tel Hashomer Hospital, Ramat Gan, Israel

    Pnina Langevitz

  5. Central Virology Laboratory, Sheba Medical Center, Tel Hashomer Hospital, Ramat Gan, Israel

    Hagit Rudnic & Zehava Grossman

Authors
  1. Tami Hod
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Giselle Zandman-Goddard
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Pnina Langevitz
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hagit Rudnic
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Zehava Grossman
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Pnina Rotman-Pikielny
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Yair Levy
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yair Levy.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hod, T., Zandman-Goddard, G., Langevitz, P. et al. Does parvovirus infection have a role in systemic lupus erythematosus?. Immunol Res 65, 447–453 (2017). https://doi.org/10.1007/s12026-017-8896-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12026-017-8896-0

Keywords

Search

Navigation